相关实验视频
Updated: Jul 8, 2025

10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
32.2K
药物遗传变异可能影响光学药物的使用
Diana Alves1, Filipa Ferreira2, Cristina Pereira2
1Medical Science Department, University of Aveiro, 3810- 193 Aveiro, Portugal.
Endocrine, metabolic & immune disorders drug targets
|December 19, 2023
概括
在FMO3和DPYD基因的遗传变异影响药物反应. FMO3变种提供了对多的保护,而DPYD变种可以在接受胺化疗的癌症患者中致命,突出了个性化医学中的药物遗传学.
科学领域:
- 药物遗传学 药物遗传学
- 基因组学就是基因组学.
- 代谢疾病 代谢疾病
背景情况:
- 单核酸多态 (SNP) 在代谢性疾病中作为药物易感性生物标志物.
- 含有黄素的单氧酶3 (FMO3) 基因的变化与苏林达克代谢和三甲基胺尿症 (TMAu) 有关.
- DPYD基因变异与二皮里米丁脱酶缺乏症 (DPD) 相关,损害了皮里米丁代谢并引起毒性.
研究的目的:
- 研究基因变异在药物代谢中的作用及其对疾病因果关系和治疗结果的影响.
- 识别影响药物有效性和毒性的特定基因变异.
- 为了强调基因分析在个性化医学中的重要性.
主要方法:
- 基因测序以识别单核酸多态 (SNP) 和变异.
- 对药物反应的基因型-表型相关性的分析.
- 审查现有的关于药物遗传学和药物代谢的文献.
主要成果:
- 同胞性FMO3多态 (c.472G>A和c.923A>G) 在家族腺瘤多重症 (FAP) 中显示出对聚发育的保护作用.
- DPYD基因变异 (c.1905+1G>A,c.1679T>G,c.2846A>T和c.1236G>A/HapB3) 与在接受基于氧胺的化疗治疗的癌症患者中具有致命的毒性有关.
- 遗传变异显著影响个人对特定药物的反应.
结论:
- 了解药物代谢机制对于预测治疗反应至关重要.
- 药物遗传学是个性化医学的重要工具,可以预测药物的疗效和毒性.
- 对药物代谢酶的分子研究改善了治疗个性化和患者安全.
相关概念视频
Nonlinear Pharmacokinetics: Role of Transporters
52
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
52
Factors Affecting Drug Biotransformation: Biological
153
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
153
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
153
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
153
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
64
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
64
Nonlinear Pharmacokinetics: Overview
385
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
385
Pharmacokinetic Models: Overview
709
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
709

